New diabetes shot aims to tame stubborn blood sugar
NCT ID NCT07387003
Summary
This study is testing an experimental injection called GZR101-80 for adults with type 2 diabetes whose blood sugar is still too high despite taking diabetes pills or insulin. Researchers want to see if this new treatment can lower blood sugar levels more effectively over 16 weeks and if it is safe. The trial will enroll about 300 participants to compare the new injection against current standard treatments.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES (T2DM) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Gan & Lee Pharmaceuticals
Beijing, China
Conditions
Explore the condition pages connected to this study.